The high prevalence of undiagnosed prostate cancer at autopsy: implications for epidemiology and treatment of prostate cancer in the Prostate-specific Antigen-era

Overdiagnosis and Overtreatment of Prostate Cancer

(2014) Stacy Loeb et al.   EUROPEAN UROLOGY

Further Evidence That Prostate-Specific Antigen Screening Reduces Prostate Cancer Mortality

(2014) M. J. Stampfer et al.   JNCI-Journal of the National Cancer Institute

Dietary Lycopene, Angiogenesis, and Prostate Cancer: A Prospective Study in the Prostate-Specific Antigen Era

(2014) K. Zu et al.   JNCI-Journal of the National Cancer Institute

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

(2014) Fritz H Schröder et al.   LANCET

Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer

(2014) Anna Bill-Axelson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Physician Variation in Management of Low-Risk Prostate Cancer

(2014) Karen E. Hoffman et al.   JAMA Internal Medicine

Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

(2013) Virginia A. Moyer   ANNALS OF INTERNAL MEDICINE

Screening for Prostate Cancer: A Guidance Statement From the Clinical Guidelines Committee of the American College of Physicians

(2013) Amir Qaseem et al.   ANNALS OF INTERNAL MEDICINE

American Urological Association (AUA) Guideline on prostate cancer detection: process and rationale

(2013) H. Ballentine Carter   BJU INTERNATIONAL

Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial

(2013) Theodore M. Brasky et al.   JNCI-Journal of the National Cancer Institute

Prevalence of Prostate Cancer on Autopsy: Cross-Sectional Study on Unscreened Caucasian and Asian Men

(2013) Alexandre R. Zlotta et al.   JNCI-Journal of the National Cancer Institute

Body mass index and incidence of localized and advanced prostate cancer—a dose–response meta-analysis of prospective studies

(2012) A. Discacciati et al.   ANNALS OF ONCOLOGY

Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial

(2012) Paul F. Pinsky et al.   Cancer Epidemiology

Prostate Cancer Screening: Facts, Statistics, and Interpretation in Response to the US Preventive Services Task Force Review

(2012) Sigrid Carlsson et al.   JOURNAL OF CLINICAL ONCOLOGY

Coffee Consumption and Prostate Cancer Risk and Progression in the Health Professionals Follow-up Study

(2011) K. M. Wilson et al.   JNCI-Journal of the National Cancer Institute

Fish consumption and prostate cancer risk: a review and meta-analysis

(2010) Konrad M Szymanski et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Dietary glycemic index, glycemic load, insulin index, fiber and whole-grain intake in relation to risk of prostate cancer

(2010) K. Nimptsch et al.   CANCER CAUSES & CONTROL

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Evidence Supports a Faster Growth Rate and/or Earlier Transformation to Clinically Significant Prostate Cancer in Black Than in White American Men, and Influences Racial Progression and Mortality Disparity

(2010) Isaac J. Powell et al.   JOURNAL OF UROLOGY

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

(2010) Jonas Hugosson et al.   LANCET ONCOLOGY

Smoking as a Risk Factor for Prostate Cancer: A Meta-Analysis of 24 Prospective Cohort Studies

(2009) Michael Huncharek et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Gleason Score and Lethal Prostate Cancer: Does 3 + 4 = 4 + 3?

(2009) Jennifer R. Stark et al.   JOURNAL OF CLINICAL ONCOLOGY

Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context

(2009) G. Draisma et al.   JNCI-Journal of the National Cancer Institute

Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers

(2008) Scott M. Lippman et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION